A Secret Weapon For LY 3000328
Other scientific trials in patients with non-Hodgkin's lymphoma [24] and patients with Superior malignancy [14] have revealed also that zosuquidar didn't appreciably affect the pharmacokinetics of doxorubicin and experienced average outcomes on the pharmacokinetics of vincristine. These clinical trials accepted that zosuquidar could safely administ